查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530758

2030 年維生素 K2 市場預測：按產品類型、成分、形式、分銷管道、應用和地區進行的全球分析

Vitamin K2 Market Forecasts to 2030 - Global Analysis By Product Type, Source, Form, Distribution Channel, Application and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球維生素 K2 市場規模為 1.596 億美元，預計到 2030 年將達到 5.747 億美元，預測期內複合年成長率為 23.8%。

維生素K2是血液凝固和骨骼代謝所必需的脂溶性維生素。它在激活調節鈣分佈的蛋白質、引導鈣到達骨骼和牙齒以及防止動脈鈣化方面發揮重要作用。 K2 支持心血管健康、骨骼強度和牙齒健康。它存在於發酵食品和動物食品中，也作為補充品出售。隨著人們健康意識的增強，它越來越受歡迎，因為它預計會對認知功能和胰島素敏感性產生影響。

健康意識不斷增強

隨著消費者越來越重視預防保健和營養食品，健康意識的提高正在推動維生素 K2 市場的發展。維生素 K2 因其在骨骼健康、心血管健康和其他生理功能方面的潛在作用而受到認可。注重健康的人們對維生素 K2 益處的認知不斷提高，積極主動的醫療保健舉措正在促進市場成長，並推動對含有維生素 K2 的補充品和強化食品的需求。

消費者意識有限

儘管人們對維生素 K2 的興趣日益濃厚，但消費者對維生素 K2 的認知較低是市場成長的主要阻礙因素。許多人不熟悉維生素 K2 的具體益處以及它與維生素 K1 的差異。這種知識的缺乏可能會導致在購買維生素 K2 產品時感到困惑和猶豫。此外，醫療保健專業人員也不熟悉維生素 K2補充品，可能不會持續推薦補充品。

高齡化社會

感測器技術的進步為維生素 K2 市場創造了重大機會。無線感測網路和先進的 pH、濁度和溶解氧氧氣感測器等創新提高了維生素 K2 的準確性和效率。這些進步實現了即時資料收集和分析，改善污染檢測和水質管理，並推動市場成長。

與其他維生素的競爭

來自其他維生素的競爭對維生素 K2 市場構成了重大威脅。在骨骼健康方面，維生素 D 和鈣等眾所周知的維生素往往被維生素 K2 所掩蓋。消費者可能會優先考慮這些熟悉的營養素而不是維生素 K2。此外，聲稱可提供全面營養支持的綜合維他命製劑可能會減少對單一維生素 K2補充品的需求。

COVID-19 的影響：

COVID-19 大流行最初透過供應鏈中斷和產量減少擾亂了維生素 K2 市場。然而，大流行增加了消費者對預防性健康措施和免疫支持的興趣。因此，人們對維生素和含有維生素 K2的補充品的興趣增加。此次疫情凸顯了整體健康和營養的重要性，並且由於消費者優先考慮健康，因此可能會推動維生素 K2 市場的長期成長。

MK-7 預計將在預測期內成為最大的細分市場

與其他形式相比，MK-7 憑藉卓越的生物利用度和較長的半衰期，預計將主導維生素 K2 市場。 MK-7 在體內保持活性較長時間，提供持久的效果。 MK-7 在低劑量下即可發揮作用，使其作為補充品配方頗具吸引力。越來越多的研究支持 MK-7 對骨骼和心血管健康的功效，這也有助於鞏固 MK-7 市場的主導地位。由於 MK-7 的有效性已得到證實，消費者和製造商越來越青睞它，從而推動了市場佔有率的成長。

預計合成材料領域在預測期內複合年成長率最高

由於多種因素，預計合成維生素 K2 細分市場的成長率最高。與天然維生素 K2 相比，合成維生素 K2 生產方法可提供一致的品質、擴充性和成本效益。這使得製造商能夠滿足不斷成長的需求，同時保持產品穩定性。合成維生素K2可以全年生產，不受天然來源的限制。生產技術的進步提高了合成維生素 K2 的純度和生物利用度，使其越來越能與天然維生素 K2 相提並論。這些因素促進了合成維生素 K2 的快速成長。

佔比最大的地區：

由於多種因素，亞太地區有望主導維生素 K2 市場。該地區人口眾多，健康意識不斷提高，增加了對營養食品的需求。日本等國家透過納豆等傳統食品攝取維生素 K2 有著悠久的歷史。在中國和印度等國家，可支配收入的增加和都市化正在推動健康產業的發展。主要維生素 K2 製造商在該地區的存在，加上強大的食品市場，有助於在亞太地區保持市場領先地位。此外，政府促進預防性醫療保健的措施也支持市場成長。

複合年成長率最高的地區：

預計亞太地區將維持維生素 K2 市場的最高成長率。快速的都市化和生活方式的改變正在增加與生活方式相關的健康問題的發生率，從而推動了對預防性補充品的需求。該地區的人口老化，特別是日本和韓國等國家的人口老化，正在為骨骼和心血管保健產品創造一個不斷成長的市場。加強消費者對營養和健康的教育正在提高維生素 K2 的認知。新興經濟體中階的擴大和醫療保健支出的增加推動了該地區維生素 K2 市場的快速成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球維生素 K2 市場：依產品類型

  • MK-4
  • MK-7
  • 其他產品類型

第6章全球維生素 K2 市場：依原料分類

  • 自然的
    • 納豆（發酵大豆食品）
    • 起司
    • 蛋
    • 其他自然資源
  • 合成

第7章全球維生素 K2 市場：依形式

  • 粉末和結晶
  • 膠囊和錠劑
  • 油和液體

第8章全球維生素 K2 市場：依通路分類

  • 網路零售
  • 實體零售業
    • 藥局
    • 專賣店
  • 醫院/診所

第9章全球維生素 K2 市場：依應用分類

  • 保健補充品
  • 藥品
  • 功能性食品和飲料
  • 化妝品
  • 營養食品
  • 其他用途

第10章全球維生素K2市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • Kappa Bioscience
  • Lesaffre
  • DSM Nutritional Products
  • NattoPharma
  • Kyowa Hakko Bio Co., Ltd.
  • Viridis BioPharma
  • Seebio Biotech（Shanghai）Co., Ltd.
  • Danisco A/S
  • Frutarom
  • Shandong Guangtongbao Pharmaceuticals Co., Ltd.
  • GeneFerm Biotechnology Co., Ltd.
  • Penglai Marine Bio-Tech Co., Ltd.
  • Herbonutra
  • J-Oil Mills, Inc.
  • Zhejiang Hisun Bio-Tech Co., Ltd.
  • Yihai Kerry Group
  • Huazhong Pharmaceutical Co., Ltd.
  • NattoPharma ASA
Product Code: SMRC26870

According to Stratistics MRC, the Global Vitamin K2 Market is accounted for $159.6 million in 2024 and is expected to reach $574.7 million by 2030 growing at a CAGR of 23.8% during the forecast period. Vitamin K2 is a fat-soluble vitamin essential for blood clotting and bone metabolism. It plays a crucial role in activating proteins that regulate calcium distribution, directing it to bones and teeth while preventing arterial calcification. K2 supports cardiovascular health, bone strength, and dental health. They are found in fermented foods and animal products and are also available as supplements. The potential benefits for cognitive function and insulin sensitivity make it increasingly popular in health-conscious circles.

Market Dynamics:

Driver:

Growing health consciousness

Growing health consciousness drives the vitamin K2 market as consumers increasingly prioritize preventive healthcare and nutritional supplements. Vitamin K2 is recognized for its role in bone health, cardiovascular health, and potentially in other physiological functions. Rising awareness about the benefits of Vitamin K2 among health-conscious individuals and proactive healthcare initiatives contribute to market growth, fostering demand for supplements and fortified foods containing Vitamin K2.

Restraint:

Limited consumer awareness

Despite growing interest, limited consumer awareness about vitamin K2 remains a significant restraint on market growth. Many people are unfamiliar with Vitamin K2's specific benefits and how it differs from Vitamin K1. This lack of knowledge can lead to confusion and hesitation when purchasing vitamin K2 products. Additionally, healthcare professionals may not consistently recommend vitamin K2 supplements due to limited familiarity.

Opportunity:

Aging population

Technological advancements in sensor technology present significant opportunities for the Vitamin K2 market. Innovations such as wireless sensor networks, advanced pH, turbidity, and dissolved oxygen sensors enhance the accuracy and efficiency of Vitamin K2. These advancements enable real-time data collection and analysis, improving contamination detection and water quality management, thus driving market growth.

Threat:

Competition from other vitamins

Competition from other vitamins poses a significant threat to the vitamin K2 market. More established and well-known vitamins like vitamin D and calcium often overshadow vitamin K2 in the bone health segment. Consumers may prioritize these familiar nutrients over vitamin K2. Additionally, multivitamin formulations that claim to provide comprehensive nutrition can reduce the perceived need for standalone vitamin K2 supplements.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the Vitamin K2 market through supply chain interruptions and reduced production. However, it also increased consumer focus on preventive health measures and immune support. This led to growing interest in vitamins and supplements, including Vitamin K2. The pandemic highlighted the importance of overall health and nutrition, potentially driving long-term growth in the Vitamin K2 market as consumers prioritize wellness.

The MK-7 segment is expected to be the largest during the forecast period

The MK-7 segment is anticipated to dominate the vitamin K2 market due to its superior bioavailability and longer half-life compared to other forms. MK-7 remains active in the body for a longer duration, providing sustained benefits. Its effectiveness in lower doses makes it attractive for supplement formulations. The growing body of research supporting MK-7's benefits for bone and cardiovascular health contributes to its market dominance. Consumers and manufacturers increasingly prefer the MK-7 for its proven efficacy, driving its larger market share.

The synthetic segment is expected to have the highest CAGR during the forecast period

The synthetic vitamin K2 segment is projected to experience the highest growth rate due to several factors. Synthetic production methods offer consistent quality, scalability, and cost-effectiveness compared to natural sources. This allows manufacturers to meet increasing demand while maintaining product stability. Synthetic vitamin K2 can be produced year-round, independent of natural source limitations. Advancements in production technologies are improving the purity and bioavailability of synthetic forms, making them increasingly comparable to natural sources. These factors contribute to the rapid growth of the synthetic segment.

Region with largest share:

Asia Pacific is poised to dominate the vitamin K2 market due to several factors. The region's large population and increasing health awareness drive demand for nutritional supplements. Countries like Japan have a long history of vitamin K2 consumption through traditional foods like natto. Growing disposable incomes and urbanization in countries like China and India are fueling the wellness industry. The presence of major vitamin K2 manufacturers in the region, coupled with a strong nutraceutical market, contributes to Asia Pacific's market leadership. Additionally, government initiatives promoting preventive healthcare support market growth.

Region with highest CAGR:

Asia Pacific is expected to maintain the highest growth rate in the vitamin K2 market. Rapid urbanization and changing lifestyles are increasing the prevalence of lifestyle-related health issues, driving demand for preventive supplements. The region's aging population, particularly in countries like Japan and South Korea, creates a growing market for bone and cardiovascular health products. Increasing consumer education about nutrition and wellness is boosting vitamin K2 awareness. The expanding middle class and rising healthcare expenditure in emerging economies contribute to the region's high growth rate in the vitamin K2 market.

Key players in the market

Some of the key players in Vitamin K2 market include Kappa Bioscience, Lesaffre, DSM Nutritional Products, NattoPharma, Kyowa Hakko Bio Co., Ltd., Viridis BioPharma, Seebio Biotech (Shanghai) Co., Ltd., Danisco A/S, Frutarom, Shandong Guangtongbao Pharmaceuticals Co., Ltd., GeneFerm Biotechnology Co., Ltd., Penglai Marine Bio-Tech Co., Ltd., Herbonutra, J-Oil Mills, Inc., Zhejiang Hisun Bio-Tech Co., Ltd., Yihai Kerry Group, Huazhong Pharmaceutical Co., Ltd. and NattoPharma ASA.

Key Developments:

In March 2024, Kyowa Hakko Bio, Co., Ltd. and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings Co., has opened its expanded citicoline manufacturing facility at its Kyowa Hakko Bio Yamaguchi Production Center in Hofu City, Yamaguchi Prefecture, Japan. With the expanded facility, the Kirin Group is planning to integrate citicoline into upcoming product development initiatives, the company said. Kyowa Hakko Bio manufactures Cognizin, a citicoline brand, through a fermentation process for health food and pharmaceutical manufacturers.

In November 2023, Lesaffre is expanding its footprint in the United States through several capital investments and acquisitions. The company, which primarily focuses on yeast, bacteria and baking ingredients, is expanding into the nutrition, health and biotechnology sectors. With the expansion, the company is investing in both new equipment and R&D. Lesaffre has added a 10th fermentor for the Red Star Yeast, LLC yeast plant in Cedar Rapids, Iowa. At the same plant, the company also invested in a new dryer for its Phileo, Lesaffre business unit focused on animal nutrition and health customer demand, the company said.

In June 2022, Fermenta Biotech and Kappa Bioscience, a Norwegian entity, have announced a strategic partnership that positions Fermenta as the distributor of Kappa's K2VITAL MCT and MCC range of vitamin K2 for the Indian market. The collaboration combines Kappa's vitamin K2 manufacturing capabilities with Fermenta's distribution network and market expertise in India.

Product Types Covered:

  • MK-4
  • MK-7
  • Product Types

Sources Covered:

  • Natural
  • Synthetic

Forms Covered:

  • Powder and Crystalline
  • Capsules and Tablets
  • Oils and Liquid

Distribution Channels Covered:

  • Online Retail
  • Brick-and-Mortar Retail
  • Hospitals & Clinics

Applications Covered:

  • Health Supplements
  • Pharmaceuticals
  • Functional Food and Beverages
  • Cosmetics
  • Nutraceuticals
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vitamin K2 Market, By Product Type

  • 5.1 Introduction
  • 5.2 MK-4
  • 5.3 MK-7
  • 5.4 Other Product Types

6 Global Vitamin K2 Market, By Source

  • 6.1 Introduction
  • 6.2 Natural
    • 6.2.1 Natto (Soybean Ferment)
    • 6.2.2 Cheese
    • 6.2.3 Eggs
    • 6.2.4 Other Natural Sources
  • 6.3 Synthetic

7 Global Vitamin K2 Market, By Form

  • 7.1 Introduction
  • 7.2 Powder and Crystalline
  • 7.3 Capsules and Tablets
  • 7.4 Oils and Liquid

8 Global Vitamin K2 Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Retail
  • 8.3 Brick-and-Mortar Retail
    • 8.3.1 Pharmacies
    • 8.3.2 Specialty Stores
  • 8.4 Hospitals & Clinics

9 Global Vitamin K2 Market, By Application

  • 9.1 Introduction
  • 9.2 Health Supplements
  • 9.3 Pharmaceuticals
  • 9.4 Functional Food and Beverages
  • 9.5 Cosmetics
  • 9.6 Nutraceuticals
  • 9.7 Other Applications

10 Global Vitamin K2 Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Kappa Bioscience
  • 12.2 Lesaffre
  • 12.3 DSM Nutritional Products
  • 12.4 NattoPharma
  • 12.5 Kyowa Hakko Bio Co., Ltd.
  • 12.6 Viridis BioPharma
  • 12.7 Seebio Biotech (Shanghai) Co., Ltd.
  • 12.8 Danisco A/S
  • 12.9 Frutarom
  • 12.10 Shandong Guangtongbao Pharmaceuticals Co., Ltd.
  • 12.11 GeneFerm Biotechnology Co., Ltd.
  • 12.12 Penglai Marine Bio-Tech Co., Ltd.
  • 12.13 Herbonutra
  • 12.14 J-Oil Mills, Inc.
  • 12.15 Zhejiang Hisun Bio-Tech Co., Ltd.
  • 12.16 Yihai Kerry Group
  • 12.17 Huazhong Pharmaceutical Co., Ltd.
  • 12.18 NattoPharma ASA

List of Tables

  • Table 1 Global Vitamin K2 Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Vitamin K2 Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Vitamin K2 Market Outlook, By MK-4 (2022-2030) ($MN)
  • Table 4 Global Vitamin K2 Market Outlook, By MK-7 (2022-2030) ($MN)
  • Table 5 Global Vitamin K2 Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 6 Global Vitamin K2 Market Outlook, By Source (2022-2030) ($MN)
  • Table 7 Global Vitamin K2 Market Outlook, By Natural (2022-2030) ($MN)
  • Table 8 Global Vitamin K2 Market Outlook, By Natto (Soybean Ferment) (2022-2030) ($MN)
  • Table 9 Global Vitamin K2 Market Outlook, By Cheese (2022-2030) ($MN)
  • Table 10 Global Vitamin K2 Market Outlook, By Eggs (2022-2030) ($MN)
  • Table 11 Global Vitamin K2 Market Outlook, By Other Natural Sources (2022-2030) ($MN)
  • Table 12 Global Vitamin K2 Market Outlook, By Synthetic (2022-2030) ($MN)
  • Table 13 Global Vitamin K2 Market Outlook, By Form (2022-2030) ($MN)
  • Table 14 Global Vitamin K2 Market Outlook, By Powder and Crystalline (2022-2030) ($MN)
  • Table 15 Global Vitamin K2 Market Outlook, By Capsules and Tablets (2022-2030) ($MN)
  • Table 16 Global Vitamin K2 Market Outlook, By Oils and Liquid (2022-2030) ($MN)
  • Table 17 Global Vitamin K2 Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 18 Global Vitamin K2 Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 19 Global Vitamin K2 Market Outlook, By Brick-and-Mortar Retail (2022-2030) ($MN)
  • Table 20 Global Vitamin K2 Market Outlook, By Pharmacies (2022-2030) ($MN)
  • Table 21 Global Vitamin K2 Market Outlook, By Specialty Stores (2022-2030) ($MN)
  • Table 22 Global Vitamin K2 Market Outlook, By Hospitals & Clinics (2022-2030) ($MN)
  • Table 23 Global Vitamin K2 Market Outlook, By Application (2022-2030) ($MN)
  • Table 24 Global Vitamin K2 Market Outlook, By Health Supplements (2022-2030) ($MN)
  • Table 25 Global Vitamin K2 Market Outlook, By Pharmaceuticals (2022-2030) ($MN)
  • Table 26 Global Vitamin K2 Market Outlook, By Functional Food and Beverages (2022-2030) ($MN)
  • Table 27 Global Vitamin K2 Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 28 Global Vitamin K2 Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 29 Global Vitamin K2 Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.